Summary.-The action of methotrexate, actinomycin D, bleomycin, vincristine and hydroxyurea on the production of human chorionic gonadotrophin (hCG) by a choriocarcinoma cell line (BeWo) has been studied. hCG production per unit of cell protein was increased, and this was a continuing process only halted by cell death.
The proportion of hCG-producing cells in the population increased from -5% to a maximum of~4 0O% during incubation with vincristine. A possible explanation for these and related observations is that cytotoxic agents promote the differentiation of cytotrophoblast to syncytium. A similar mechanism could contribute to the unusual sensitivity of choriocarcinoma to cytotoxic agents.
HUMAN CHORIONIC GONADOTROPHIN
(hCG) is synthesized by the syncytiotrophoblastic cells of the placenta and of trophoblastic tumours. It is also known to be synthesized in small amounts by some other tissues, and by a variety of nontrophoblastic tumours (Bagshawe et al., 1979) . hCG consists of two different noncovalently linked subunits. Measurement of serum or urine hCG by immunoassay using antisera directed at the a-subunit is standard practice in the management of both gestational and non-gestational trophoblastic tumours, which are unusually responsive to cytotoxic agents.
The administration of effective cytotoxic therapy to a patient with choriocarcinoma commonly increases the serum and urine hCG concentrations which remain high for several days before values fall, and it has been suggested that the initial peak might be due to lysis of cells releasing preformed hCG. Several reports have indicated that when choriocarcinoma cells growing in vitro are exposed to certain cytotoxic agents, the amount of hCG secreted into the medium is greatly increased (Hussa et al., 1973; Speeg et al., 1976 (GIBCO) supplemented with 10% (v/v) foetal calf serum and penicillin (100 u/ml) and streptomycin (100 pg/ml).
To determine the effects of antimetabolites on hCG production, the cells were harvested from monolayer culture with a trypsin-EDTA solution (0.5% trypsin 1:250 and 0.2% EDTA in normal saline) and their concentration adjusted to 2-0 x 105/ml. This cell suspension was added to multi-well plates (Sterilin product No. 313) at 1P5 ml/well and the cells allowed to attach for 24 h. The medium was removed, and to each well was added 1-5 ml of fresh culture medium (control) or medium containing MTX, AD, BLM, VCR or HU. At intervals thereafter the medium was collected from each well and fresh antimetabolite solutions added. The collected medium was centrifuged to remove particulate material and stored at -20°C for subsequent radioimmunoassay.
Cell protein was determined by the Lowry method using bovine serum albumin as standard. The cell monolayers were washed x 3 with normal saline and stored at -20°C until they could be conveniently assayed. Then 5 ml of Lowry's solution C was added to each well to dissolve the cells. To assist dissolution the monolayers were scraped with a rubber policeman.
Radioimmunoassay ofhCG.-The concentration of hCG-reactive material in unfractionated culture medium was measured by a double-antibody radioimmunoassay (Kardana & Bagshawe, 1976) in which primary and secondary antibodies were preincubated, the standard was intact hCG labelled with 1251 by the chloramine-T method and the assay incubation time was 18 h at 37°C. Assay sensitivity was 2-4 mIU/ml. The primary antiserum was raised by injecting rabbits with purified , subunit of hCG. This antiserum displayed less than 10% crossreactivity with human luteinizing hormone.
To every assay tube 100 /l of culture medium was added, so that nonspecific effects due to differences in pH, osmolarity or protein concentration between culture medium and the assay buffer were eliminated. None of the antimetabolites used interfered with the radioimmunoassay.
The culture media were also subjected to radioimmunoassay for the syncytiotrophoblastic proteins, human placental lactogen and pregnancy-specific B1SP glycoprotein. At no stage in the control or drug-treated cultures were these proteins detected.
Immunocytochemical demonstration of hCG. -BeWo cells growing in monolayer culture were washed in PBS (pH 7.5), fixed for 30 min in neutral buffered formalin, washed again in PBS, and allowed to dry. A 30 min pre-incubation in PBS containing 20% (v/v) normal swine serum was followed by a 30 min incubation with rabbit anti-hCG diluted in PBS +20% normal swine serum. After washing with PBS the cells were incubated for 30 min with swine anti-rabbit-IgG, washed again and incubated with peroxidase/rabbit anti-peroxidase complexes for 30 min. Finally, the cells were washed and incubated for 5 min in PBS containing 0.05% (w/v) 3,3-diaminobenzidine tetrahydrochloride and 0.01% (v/v) hydrogen peroxide. After staining with haematoxylin the percentage of positively stained cells was determined.
Rabbit anti-hCG preincubated with hCG was used as a control for the specificity of the staining reaction. This gave a negative reaction with the cells.
RESULTS
All the cytotoxic agents tested had similar effects on BeWo hCG production. Fig. 1 (a-e) shows that these drugs stimulated a dose-dependent increase in the amount of hCG released into the culture medium. This increase reached a peak between 2 and 6 days of incubation, after which hCG levels fell away to less than control values.
A Thus stimulation of hCG production in vitro, rather than being a transitory phenomenon associated with the early stages of incubation with a cytotoxic agent, is essentially a continuing process which is only halted by cell death.
The effect of the 5 agents on total cell protein varied with dose. Taking those drug concentrations optimal for enhancement of hCG production (10-6-10-8M for MTX, 10-8M for AD. 10 ,ug/ml for BLM, 25 u -10-6-10-7M for VCR and 10-2M for HU) with all 5 agents there was an initial period during which levels of cell protein per culture rose, though at a lower rate than in the control cultures, but as incubation continued cell protein levels fell and there was a corresponding increase in cell debris. The duration of the period in which cell protein was increasing differed between the drugs, being greatest with MTX. Indeed with 10-7 and 10-8M MTX, no decrease was observed, that is, cell protein continued to increase throughout the incubation, while with 10-6M MTX cell protein did not begin to decrease until after 9 days of incubation. With 10-6M VCR and 10-8M AD, cell protein declined from Day 2 of incubation whilst with 10 jig/ml BLM and 1O-2M HU, levels began to fall from Day 3 of incubation. BeWo cell protein was undetectable after 9 days' incubation with 10-8M AD, after 10 days with 1O-2M HU and after 12 days' incubation with 1O-6M VCR. From this it may be deduced that enhancement of hCG production is obtained at drug concentrations which, though not immediately cytotoxic, eventually lead to cell death.
Immunocytochemicat demonstration of hCG
BeWo cultures were incubated for 3 days with various concentrations of VCR Table, where it can be seen that incubation with VCR increased the percentage of hCG+ positive cells, and that the concentration of VCR stimulating the greatest increase in culture-medium hCG levels was also that which produced the greatest percentage of hCG+ cells.
DISCUSSION
Attention has been paid to the regulation of hCG synthesis in cultured choriocarcinoma cells (Hussa et al., 1973 (Hussa et al., , 1977 Speeg et al., 1976; Azizkhan et al., 1979) and in other cell lines such as HeLa which ectopically produce subunits of hCG (Ghosh et al., 1977; Fallon & Cox, 1979) . There is now a large body of data on the manner in which this synthesis is stimulated by agents which otherwise inhibit cell metabolism, though as yet no convincing explanation has been advanced to account for this stimulation.
That a variety of cytotoxic agents with different modes of action were found to stimulate hCG synthesis suggests that, if a common biochemical lesion is involved, it must be of a very general nature. However, this stimulation is not simply an effect of agents which are toxic to BeWo cells (Hussa et al., 1973) . Indeed, as the dose-dependence of the phenomenon suggests, excessive toxicity may prevent the enhancement of hormone production. Also, dibutyryl cyclic AMP, but not equimolar cyclic AMP, stimulates hCG synthesis (Hussa et al., 1977) , though the latter is apparently a greater inhibitor of BeWo growth, and produces more cell death (Barker & Isles, 1977) .
A stimulator must therefore have a relatively selective effect on cell function. Attention has been drawn to the correlation between inhibition of DNA synthesis and stimulation of hCG production. Azizkhan et al. (1979) have reported that removal of hCG-inducing antimetabolites from JAr cultures (another hCG-synthe-sizing trophoblastic cell line) causes less enhancement of hCG synthesis, which is chronologically related to disinhibition of DNA synthesis. However, the mechanism(s) relating inhibition of DNA synthesis to enhanced hCG production are unknown. One possibility which has been mooted is that hCG-inducing antimetabolites may arrest cycling cells in a phase of the cell cycle at which hCG synthesis is maximal (Speeg et al., 1976; Azizkhan et al., 1979) . Fallon & Cox (1979) (Friedman & Skehan, 1979) .
In the placenta the syncytiotrophoblast is formed from the cytotrophoblast, apparently by cell fusion, and further cell division does not appear to occur. With immunocytochemical techniques, hCG appears to be localized to the syncytial cells (Midgley & Pierce, 1962; de Ikonicoff & Cedard, 1973) and in trophoblastic tumours the situation appears to be similar. When we have stained choriocarcinomas by the immunoperoxidase technique, hCG appears to be confined to large syncytial cells (unpublished observations) and this is in line with the results of others (Midgley & Pierce, 1962; Kameya et al., 1977) . Against this there are reports that hCG can be localized to cytotrophoblastic cells, as well as the syncytiotrophoblast, in placenta (Hoshina et al., 1979) and in choriocarcinomas (Gartner et al., 1975 This suggests the hypothesis that the unusual sensitivity of trophoblastic tumours to agents inhibiting DNA synthesis may be due at least in part to the promotion of differentiation to short-lived endcells.
The intra-tumour drug concentrations that are achieved in choriocarcinoma patients on chemotherapy are not known. Consequently it is difficult to relate the optimal hCG-enhancing doses, derived from our in vitro studies, to the clinical situation. The peak blood concentrations that occur with conventional chemotherapeutic dose schedules may be looked at. There are studies on patients undergoing chemotherapy in which the peak plasma concentrations ofMTX (Chabner, 1979) , AD (Tattersall et al., 1975) , BLM, (Teale et al., 1977) , VCR (Bender et al., 1977) and HU (Belt et al., 1980) are, albeit transiently within an order of magnitude of the concentrations of these agents which we found optimally enhanced BeWo hCG production in vitro. Obviously intra-tumour drug levels will differ from plasma levels, but the studies referred to do at least indicate that the optimum in vitro concentrations are not wildly different from those that occur in patients receiving chemotherapy.
